<?xml version="1.0"?> <template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">   <id>5eb647f6-cefe-431c-95fc-52c5f34f5512</id>   <name>COVID-19 Infectious Diseases Antiviral Agents Order Panel</name>   <description>     <lifecycle_state>Initial</lifecycle_state>     <details>       <purpose />       <use />       <misuse />     </details>     <other_details>       <item>         <key>MetaDataSet:Sample Set </key>         <value>Template metadata sample set </value>       </item>       <item>         <key>Acknowledgements</key>         <value />       </item>       <item>         <key>Business Process Level</key>         <value />       </item>       <item>         <key>Care setting</key>         <value />       </item>       <item>         <key>Client group</key>         <value />       </item>       <item>         <key>Clinical Record Element</key>         <value />       </item>       <item>         <key>Copyright</key>         <value />       </item>       <item>         <key>Issues</key>         <value />       </item>       <item>         <key>Owner</key>         <value />       </item>       <item>         <key>Sign off</key>         <value />       </item>       <item>         <key>Speciality</key>         <value />       </item>       <item>         <key>User roles</key>         <value />       </item>     </other_details>   </description>   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]">     <items>       <item>         <key>Technical.ï»© Technical Traceability</key>         <value>{~AHSID~5eb647f6-cefe-431c-95fc-52c5f34f5512~NAME~COVID-19 Infectious Diseases Antiviral Agents Order Panel.oet}</value>       </item>     </items>   </annotations>   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">     <items>       <item>         <key>CKT.Clinical Guidance</key>         <value>&lt;p&gt;&lt;em&gt;For ventilated patients ONLY&lt;/em&gt;&lt;/p&gt;</value>       </item>     </items>   </annotations>   <definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="COVID-19 Infectious Diseases Antiviral Agents Order Panel">     <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="fa80ca89-b938-4053-b4ab-6eaf57409b6f" concept_name="PLACEHOLDER Order Item" max="1" path="/items" name="lopinavir-ritonavir Tablet 400 mg-100 mg (KALETRA); 1 tablet, Oral, 2 times per day, for 14 days. On unit" />     <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="hydroxychloroquine tablet">       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="e77fba2a-c96b-4252-af3b-a97c61c7e265" concept_name="PHARM hydroxychloroquine Tablet Order" max="1" path="/items" name="hydroxychloroquine Tablet; 400 mg, Oral, 2 times per day, for 2 doses. On unit" />       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="e77fba2a-c96b-4252-af3b-a97c61c7e265" concept_name="PHARM hydroxychloroquine Tablet Order" max="1" path="/items" name="hydroxychloroquine Tablet; 200 mg, Oral, 2 times per day, for 8 doses, starting 24 hours after initial 400 mg dose. On unit" />     </Item>     <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Clinical Guidance #1" />     <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="fa80ca89-b938-4053-b4ab-6eaf57409b6f" concept_name="PLACEHOLDER Order Item" max="1" path="/items" name="remdesivir; 200 mg Intravenous, once, loading dose. On unit" />     <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="fa80ca89-b938-4053-b4ab-6eaf57409b6f" concept_name="PLACEHOLDER Order Item" max="1" path="/items" name="remdesivir; 100 mg Intravenous, daily, for 9 days, starting 24 hours after initial 200 mg loading dose. On unit" />   </definition>   <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">     <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>   </integrity_checks>   <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">     <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>   </integrity_checks>   <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.orderable_section.v1">     <digest id="MD5-CAM-1.0.1">A89AC74BC8CAD3F0719579389C69006F</digest>   </integrity_checks>   <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1">     <digest id="MD5-CAM-1.0.1">230A8D964017E1FD7AC82EBDEE0202A6</digest>   </integrity_checks>   <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1">     <digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest>   </integrity_checks> </template>